Skip navigation

Please use this identifier to cite or link to this item:
Title: Molecular structure, in vitro anticancer study and molecular docking of new phosphate derivatives of betulin
Authors: Chrobak, Elwira
Jastrzębska, Maria
Bębenek, Ewa
Kadela-Tomanek, Monika
Marciniec, Krzysztof
Latocha, Małgorzata
Wrzalik, Roman
Kusz, Joachim
Boryczka, Stanisław
Keywords: natural compounds; betulin; anticancer study; molecular docking; EGFR
Issue Date: 2021
Citation: "Molecules" Vol. 26, iss. 3 (2021), art. no. 737
Abstract: A series of 30-diethylphosphate derivatives of betulin were synthesized and evaluated for their in vitro cytotoxic activity against human cancer cell lines, such as amelanotic melanoma (C-32), glioblastoma (SNB-19), and two lines of breast cancer (T47D, MDA-MB-231). The molecular structure and activities of the new compounds were also compared with their 29-phosphonate analogs. Compounds 7a and 7b showed the highest activity against C-32 and SNB-19 cell lines. The IC50 values for 7a were 2.15 and 0.91 M, and, for 7b, they were 0.76 and 0.8 M for the C-32 and SNB-19 lines, respectively. The most potent compounds, 7a and 7b, were tested for their effects on markers of apoptosis, such as H3, TP53, BAX, and BCL-2. For the whole series of phosphate derivatives, a lipophilicity study was performed, and the ADME parameters were calculated. The most active products were docked to the active site of the EGFR protein. The relative binding affinity of selected phosphate betulin derivatives toward EGFR was compared with standard erlotinib on the basis of ChemScore and KDEEP score. Positively, all derivatives docked inside the cavity and showed significant interactions. Moreover, a molecular dynamics study also reveals that ligands 7a,b form stable complexes and the plateau phase started after 7 ns.
DOI: 10.3390/molecules26030737
ISSN: 1420-3049
Appears in Collections:Artykuły (WNŚiT)

Files in This Item:
File Description SizeFormat 
Kusz_Molecular_structure_in_vitro_anticancer_study_and_molecular_docking.pdf2,71 MBAdobe PDFView/Open
Show full item record

Uznanie Autorstwa 3.0 Polska Creative Commons License Creative Commons